Healthcare provider profile · identity verified

Michael Herbert Hoffman, MD

Family Practice · MANITOWOC, WI · NPI 1013080894

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	516	155
Levothyroxine Sodium	Levothyroxine Sodium	441	109
Lisinopril	Lisinopril	353	105
Omeprazole	Omeprazole	351	100
Amlodipine Besylate	Amlodipine Besylate	314	84
Gabapentin	Gabapentin	294	61
Alprazolam	Alprazolam	258	43
Losartan Potassium	Losartan Potassium	222	70
Sertraline Hcl	Sertraline Hcl	216	57
Metoprolol Succinate	Metoprolol Succinate	211	64
Furosemide	Furosemide	204	74
Hydrochlorothiazide	Hydrochlorothiazide	198	66
Pantoprazole Sodium	Pantoprazole Sodium	197	53
Rosuvastatin Calcium	Rosuvastatin Calcium	196	64
Metformin Hcl	Metformin Hcl	188	63
Albuterol Sulfate Hfa	Albuterol Sulfate	184	68
Simvastatin	Simvastatin	180	54
Tamsulosin Hcl	Tamsulosin Hcl	166	46
Oxycodone Hcl	Oxycodone Hcl	152	14
Lorazepam	Lorazepam	146	39
Escitalopram Oxalate	Escitalopram Oxalate	138	29
Metoprolol Tartrate	Metoprolol Tartrate	138	46
Allopurinol	Allopurinol	130	38
Warfarin Sodium	Warfarin Sodium	118	29
Tramadol Hcl	Tramadol Hcl	116	32
Eliquis	Apixaban	113	32
Tizanidine Hcl	Tizanidine Hcl	108	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	106	26
Carvedilol	Carvedilol	105	28
Citalopram Hbr	Citalopram Hydrobromide	103	24
Quetiapine Fumarate	Quetiapine Fumarate	101	21
Clopidogrel	Clopidogrel Bisulfate	97	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	96	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	24
Bupropion Xl	Bupropion Hcl	83	21
Meloxicam	Meloxicam	81	32
Trazodone Hcl	Trazodone Hcl	80	36
Potassium Chloride	Potassium Chloride	76	22
Prednisone	Prednisone	75	33
Ropinirole Hcl	Ropinirole Hcl	74	14
Glipizide	Glipizide	73	20
Pravastatin Sodium	Pravastatin Sodium	71	19
Mirtazapine	Mirtazapine	70	16
Paroxetine Hcl	Paroxetine Hcl	68	17
Zolpidem Tartrate	Zolpidem Tartrate	67	suppressed
Ezetimibe	Ezetimibe	64	16
Pregabalin	Pregabalin	64	13
Glimepiride	Glimepiride	63	17
Fluticasone Propionate	Fluticasone Propionate	62	25
Glipizide Er	Glipizide	60	18
Duloxetine Hcl	Duloxetine Hcl	59	21
Metformin Hcl Er	Metformin Hcl	59	18
Pioglitazone Hcl	Pioglitazone Hcl	56	17
Atenolol	Atenolol	55	18
Clonidine Hcl	Clonidine Hcl	55	12
Spironolactone	Spironolactone	55	13
Baclofen	Baclofen	49	suppressed
Nystatin	Nystatin	49	27
Finasteride	Finasteride	45	12
Synthroid	Levothyroxine Sodium	45	12
Amoxicillin	Amoxicillin	44	32
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	17
Fluoxetine Hcl	Fluoxetine Hcl	44	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	44	32
Famotidine	Famotidine	43	18
Acetaminophen-Codeine	Acetaminophen With Codeine	42	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	12
Montelukast Sodium	Montelukast Sodium	39	12
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Digoxin	Digoxin	38	suppressed
Nitroglycerin	Nitroglycerin	38	22
Chlorthalidone	Chlorthalidone	37	11
Fenofibrate	Fenofibrate	37	suppressed
Clonazepam	Clonazepam	36	suppressed
Jardiance	Empagliflozin	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	11
Alendronate Sodium	Alendronate Sodium	34	suppressed
Azithromycin	Azithromycin	33	27
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	11
Lamotrigine	Lamotrigine	33	11
Ondansetron Hcl	Ondansetron Hcl	32	18
Diazepam	Diazepam	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Ketoconazole	Ketoconazole	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Morphine Sulfate Er	Morphine Sulfate	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	12
Propranolol Hcl	Propranolol Hcl	27	suppressed
Temazepam	Temazepam	27	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	25	suppressed
Gemfibrozil	Gemfibrozil	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	15
Fluconazole	Fluconazole	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Cephalexin	Cephalexin	20	16
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	17
Droplet Pen Needle	Pen Needle, Diabetic	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Morphine Sulfate	Morphine Sulfate	17	16
Mupirocin	Mupirocin	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	16	suppressed
Ozempic	Semaglutide	16	suppressed
Lacosamide	Lacosamide	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Ondansetron Odt	Ondansetron	14	13
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Ocaliva	Obeticholic Acid	13	suppressed
Primidone	Primidone	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Diclofenac Potassium	Diclofenac Potassium	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nystop	Nystatin	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nexium	Esomeprazole Magnesium	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error